BCLI

BRAINSTORM CELL THERAPEUTICS

BCLI·10501E201·US·Common Stock·Healthcare - Biotechnology

BCLI institutional ownership changes in Q3 2025: 0 institutions opened or added positions, 14 trimmed or exited. BCLI (BRAINSTORM CELL THERAPEUTICS) is held by 2 institutional investors as of Q3 2025. Top institutional shareholders: OSAIC HOLDINGS, INC. ($1,351), Steward Partners Investment Advisory, LLC ($80). Net institutional sentiment: Bearish.

2
Holders
$1,431
Total Value
0% (14)
Consensus
0 buying - 14 selling
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold BCLI.

Top Holders

Checking access…
Action
Unchanged
1,785$1,3510.0%-99.43%
0
Unchanged
113$800.0%-98.82%
0
Exited
0(-100.0%)$11,9820.0%-33.96%
0
Exited
0(-100.0%)$270.0%-70.46%
0
Exited
0(-100.0%)$61,1430.0%-68.96%
0
Exited
0(-100.0%)$1,4990.0%-70.46%
0
Exited
0(-100.0%)$70.0%-60.05%
0
Exited
0(-100.0%)$2290.0%-41.18%
0
Exited
0(-100.0%)$13,8650.0%-51.67%
0
Exited
0(-100.0%)$28,1930.0%-70.46%
0
Exited
0(-100.0%)$5,7770.0%-33.96%
0
Exited
0(-100.0%)$6,4990.0%-65.60%
0
Exited
0(-100.0%)$31,0510.0%-70.46%
0
Exited
0(-100.0%)$1520.0%-66.44%
0
Exited
0(-100.0%)$110.0%-86.27%
0
Exited
0(-100.0%)$7430.0%-33.96%
0
BCLIBCLIBRAINSTORM CELL THERAPEUTICS

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used